February 28, 2022 - Imaging Endpoints guides biopharma companies in protocol development and manages the central imaging review for many clinical trials aimed at the diagnosis and treatment of rare diseases. Rare Disease Day, observance on February 28, is designed… Read More
February 24, 2022 - Immunotherapy is the most promising cancer treatment for many patients. As the world’s largest oncology focused imaging CRO, Imaging Endpoints utilizes novel response criteria, including pseudoprogression analysis, to optimize data on patient response in all phases… Read More
February 22, 2022 - Imaging Endpoints is continuing its trajectory of growth – the largest oncology-focused imaging CRO (iCRO) globally, and likely the fastest growing imaging CRO (iCRO). We are looking for talented, motivated and best-in-class individuals to join our… Read More
February 17, 2022 – Imaging Endpoints is known for superior science and the exceptional quality of our work in clinical trials. This is evidenced through our exceptional client retention rate over the last decade – in addition to adding new… Read More
February 15, 2022 - Imaging Endpoints supports many studies involving new treatments for childhood cancers, including recent new treatment approvals, and is a strong supporter of International Childhood Cancer Day which is being observed on February 15. Being diagnosed with… Read More
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
